Protein O-mannose b1,2-N-acetyglucosaminyltransferase 1 (POMGnT1) is an enzyme involved in the synthesis of O-mannosyl glycans. Mutations of POMGnT1 in humans result in the muscle-eye-brain (MEB) disease. In this study, we have characterized a null mutation generated by gene trapping with a retroviral vector inserted into the second exon of the mouse POMGnT1 locus. Expression of POMGnT1 mRNA was abolished in mutant mice. Glycosylation of a-dystroglycan was also reduced. POMGnT1 mutant mice were viable with multiple developmental defects in muscle, eye, and brain, similar to the phenotypes observed in human MEB disease. The present study provides the first genetic animal model to further dissect the roles of POMGnT1 in MEB disease. q
Introduction
Muscle-eye-brain disease (MEB) is one of a family of autosomal recessive syndromic disorders that include WalkerWarburg syndrome (WWS), Fukuyama congenital muscular dystrophy (FCMD) and congenital muscular dystrophy 1D (MDC1D) (Santavuori et al., 1989) . The common clinical manifestations are severe muscular dystrophy, ocular defects, and mental retardation. Among these muscular dystrophies, WWS is the most lethal syndrome in which patients usually die in infancy with few surviving to 3 years of age; while patients with MEB or FCMD may reach adulthood. FCMD is one of the most common genetic disorders in Japan (Fukuyama et al., 1981; Kobayashi et al., 1998) and recent studies provide evidence that MEB exists worldwide (Taniguchi et al., 2003) .
MEB, WWS, FCMD and MDC1D have been linked to defects in the genes POMGnT1 ), POMT1 and POMT2 (Beltran-Valero de Bernabe et al., 2002; van Reeuwijk, et al., 2005) , FCMD (Hayashi et al., 2001) and LARGE (Longman et al., 2003) , respectively. They encode known or putative glycosyltransferases, O-mannose b1,2-Nacetylglucosaminyltransferase (POMGnT1; Yoshida et al., 2001) , protein O-mannosyltransferase 1 (POMT1 and 2; Beltran-Valero de Bernabe et al., 2002; van Reeuwijk, et al., 2005) , fukutin (Hayashi et al., 2001) and Large (Longman et al., 2003) . Fukutin-related protein (FKRP) has high homology to fukutin. Mutations in FKRP have been associated with two types of inherited muscular dystrophies, MDC1C and LGMD2I. Surprisingly, some FKRP mutations can cause MEB or WWS like symptoms (Beltran-Valero de Bernabe, 2004) . A common molecular defect for these four human genetic diseases is the disruption of post-translational modifications of a-dystroglycan (a-DG; Moore et al., 2002; Michele et al., 2002) or hypoglycosylation of a-dystroglycan. Dystroglycan is the central protein in the dystrophinglycoprotein-complex (DGC) in which the C-terminus of extracellular a-dystroglycan binds to N-terminus of transmembrane b-dystroglycan, providing spatial linkage between the extracellular matrix and the cytoskeleton in muscle and non-muscle tissues (Campbell, 1995; Durbeej et al., 1998; Brancaccio, 2003) . a-Dystroglycan is a high-affinity receptor for a variety of extracellular ligands such as laminin, agrin, neurexin and perlecan (Michele and Campbell, 2003; Montanaro and Carbonetto, 2003) . It is highly glycosylated and its O-linked oligosaccharides are essential for molecular recognition and ligand binding (Smalheiser and Kim, 1995; Chiba et al., 1997; Brown et al., 1999) . Further study has shown that a-dystroglycan has O-linked mannosyl glycans containing the GlcNAcb1-2Man linkage (Chiba et al., 1997; Smalheiser et al., 1998) .
O-mannosylation is a very common protein modification in yeast where the O-mannosylated glycoproteins are mostly located in the cell wall. Attachment of O-linked mannosyl residues to proteins is essential for cell viability, morphology and cell wall integrity (Strahl-Bolsinger et al., 1999) . Unlike in yeast and fungi, mammalian O-mannosylation is a rare but critical type of protein modification observed in a limited number of glycoproteins of brain, nerve, and skeletal muscle, such as brain proteoglycans, a-dystroglycan and J1/tenascin (Endo, 1999) . The biosynthetic pathway of O-mannosylation in yeast is well known. Yet, the synthetic pathway of O-mannosylation in mammals is still not fully understood. Mutations in POMT1, POMGnT1, FCMD and LARGE are known to cause disruption in the glycosylation of a-dystroglycan but the reactions catalyzed by these putative enzymes, with the exception of POMGnT1, remain unknown. It is believed that the first step of O-mannosylation in mammals is catalyzed by POMT1 (Beltran-Valero de Bernabe et al., 2002; Michele and Campbell, 2003) possibly in cooperation with POMT2 (Manya et al., 2004) . The second step is catalyzed by POMGnT1, which transfers N-acetylglucosamine (GlcNAc) via b1,2 linkage to a-linked mannosyl glycoproteins (Takahashi et al., 2001; Yoshida et al., 2001) . Although the specific role of fukutin and Large is unclear, the similar molecular weight shift of core a-dystroglycan in FCMD and MEB patients and Large myd mice suggests they may be involved in an early stage of O-mannosyl glycan elongation Holzfeind et al., 2002) . A more recent study revealed that interaction between Large and N-terminal domain of a-dystroglycan is necessary to initiate glycosylation . Overexpression of Large can rescue the defects of a-dystroglycan in cells derived from patients with FCMD, WWS, MEB, and from Large myd mice . Nevertheless, how these glycosylation enzymes are coordinated in vivo to make functional a-dystroglycan remains unclear.
The POMGnT1 gene consists of 21 exons located on chromosome 1p34.1 encoding a 660-amino acid type II transmembrane protein (Cormand et al., 1999; Yoshida et al., 2001) . POMGnT1 seems to be widely expressed, since a 2.7-kb transcript was detected in all normal human tissues examined; an additional weaker 3.4-kb signal was also observed in several tissues, suggesting the existence of second initiation site or alternative splicing in these tissues ). Molecular genetic studies have identified 13 different mutations distributed over the entire POMGnT1 gene in patients with MEB.
Although the common pathogenic feature in these muscular dystrophies is the interruption of the link between the extracellular matrix and the cytoskeleton, the functional differences between each mutated protein with exception of POMGnT1, are still not completely understood. Gene knockout studies have shown that deletion of fukutin and POMT1 result in embryonic lethality (Takeda et al., 2003; Willer et al., 2004) . Currently, the myodystrophy mouse (Large myd ) is the only animal model for studying this type of congenital muscular dystrophy. It is anticipated that the glycosylation enzymes involved in muscular dystrophy function differentially in the assembly of functional a-dystroglycan complex. Thus, an animal model for each enzyme may be needed to dissect the unique molecular mechanism of each protein.
Here, we show that the loss of POMGnT1 through genetrapping results in multiple developmental defects in muscle, eye, and brain, the syndrome observed in human MEB. The availability of POMGnT1-deficient mouse model is expected to assist efforts to understand the function of this enzyme.
Results

Generation of POMGnT1 mutant mice
A DNA sequence search against OmniBank gene-trap ES cell library generated by Lexicon Genetics Incorporated (The Woodlands, TX) by using human POMGnT1 revealed the OST179231 sequence, which is approximately 95% matching a nucleotide region 41-228 of the mouse POMGnT1 cDNA (AB053220) counting from initiation codon (data not shown). OST179231 ES cell clone was used to generate POMGnT1 mutant mice. The POMGnT1 locus consists of 21 exons and 20 introns. In OST179231 ES cells, the gene-trapping cassette (Zambrowicz et al., 1998) was inserted into exon 2 of the mouse POMGnT1 gene. The insertion site was located in the 5 0 -UTR, 35 nucleotides before the initiation codon of the mouse POMGnT1 gene (Fig. 1B) . The endogenous POMGnT1 promoter therefore, directs the expression of a fusion transcript derived from the partial 5 0 -UTR of mouse POMGnT1 gene, the b-galactosidase and neomycin resistance genes from gene trapping cassette (Fig. 1B) . The gene-trapping vector also contains its own Pgk promoter that would direct the transcription of the gene trapping cassette Btk gene and then splice into the downstream reading frame of the POMGnT1 gene. The selectable marker gene Btk contains termination codons in its reading frame, which will prevent the translation of the downstream POMGnT1 transcript. Therefore, we expected that the function protein of POMGnT1 in OST179231 ES-derived gene trapping mice would be completely disrupted.
A representative genotyping result generated by PCR amplification was shown in Fig. 1C , in which nine newborns from heterozygous crossings were examined with primers flanking the upstream insertion site of the gene-trapping vector. Results indicated that samples 1, 2, 3, 5 and 6 came from heterozygous, samples 4 and 7 from wildtype, and samples 8 and 9 from homozygous mice, respectively.
To determine if any POMGnT1 mRNA can be detected, a pair of specific primers located between exon 17 and 20 of POMGnT1 was used to amplify a 217 bp DNA fragment. As shown in Fig. 1D , total RNA from a heterozygous mouse generated an expected PCR product (217 bp), RNA from a homozygote completely failed to produce such product. As a control, a pair of b-actin primers generated the expected PCR products and showed equivalent intensities on the gel. This result indicates that gene-trapping cassette insertion into the POMGnT1 locus knocked out its expression.
Reduced fertility in homozygous mice
The proportion of wildtype, heterozygous, and homozygous pups born from heterozygote matings concurred with a Mendelian distribution. Although apparently viable, POMGnT1 mutant mice are notably smaller than their littermates during the first two days after birth. The lifespan of the mutant mice are variable with a few die during adolescence. Most mutant animals, however, reach adulthood (more than 2 months old). Some mutant animals survive more than 20 months before being sacrificed. Matings of sexually mature POMGnT1 mutant mice with wildtype or heterozygous mice were not efficient. Male POMGnT1 mutant mice never produced any offspring (nZ5) while female POMGnT1 mutant produced smaller litters of up to five pups. The size and gross anatomy of mutant testis were not different from the wildtype mice, and sperm morphology and motility of mutant mice appeared normal (data not shown).
Reduced glycosylation of a-DG in mutant mice
It has been shown that the function of a-DG depends on O-type glycosylation (Endo, 1999) . Expression of the functional glycosylated a-DG is not detected in patients with FCMD, MEB and WWS, and in mice with Large myd disease (Michelele et al., 2002 , Grewal et al., 2001 . In this study, two antibodies that recognize different epitopes of the a-DG were used: IIH6C4 and VIA4-1. IIH6C4 reacts with the glycosylated laminin binding site of the a-DG (Ervasti and Campbell, 1993; Longman et al., 2003) , and the VIA4-1 recognizes an unidentified glycosylated epitope of the a-DG (Longman et al., 2003) . As expected, the monoclonal antibody IIH6C4 and VIA4-1 detected a band for a-DG in skeletal muscles of homozygous and heterozygous mice while no detectable signals were found in mutant skeletal muscle ( Fig. 2A,B) , suggesting a disruption in normal glycosylation of a-DG. To determine if the glycosylationdisrupted a-DG can bind to laminin, ligand overlay assay was performed. As shown in Fig. 2C , the laminin binding activity of a-DG was detected in both C/C and C/K mice, no significant binding activity was observed in mutant (K/K) mouse. The band above 250 kD is from WGA-enriched glycoproteins samples and not from overlayed laminin. Western blot analysis without laminin overlay identified the same band above 250 kD in skeletal muscles of C/C, C/K and K/K mice (Fig. 2D ). Similar amount of laminin was observed in wildtype, heterozygous, and homozygous samples, suggesting equivalent amounts of WGA-enriched glycoproteins were applied in all three samples. In addition, the expression of b-DG appeared to be also not affected (Fig. 2E) .
To further examine if the a-DG is hypoglycosylated, we carried out immunofluorescence staining of skeletal muscle with the IIH6C4 and anti-cranin antibodies. Results showed that strong staining signals were detected in skeletal muscle of wildtype mice ( Fig. 3E ) with monoclonal antibody IIH6C4, suggesting that glycosylated a-DG was present on the fiber membrane of skeletal muscle of wildtype mice. However, no significant staining signal was observed in skeletal muscle of homozygous mutant mice (Fig. 3F) , indicating the level of this carbohydrate epitope was greatly reduced in POMGnT1 mutant mice. By contrast, the expression of a-DG polypeptide appeared to be normal in mutant skeletal muscle as the intensities of staining are similar (Fig. 3C,D) . As a control, the expression of b-DG was not affected in the skeletal muscle of wildtype and mutant mice (Fig. 3A,B) . Thus, a-dystroglycan in the mutant skeletal muscle is hypoglycosylated when compared to that in the wildtype.
Muscular pathology in POMGnT1 mutant mice
The wildtype mice usually stretch their limbs when lifted by the tail, but POMGnT1 mutant mice folded their limbs towards the trunk (compare Fig. 4A ,B). This clasping gesture is similarly observed in fukutin-deficient chimeric mice and in Large myd mice, suggesting a common dysfunctional mechanism involved in these mutant animals (Takeda et al., 2003) . However, this phenotype is not specific to congenital muscular dystrophies and is also found in other types of mutants such as the Reeler mice. Thus, the clasping gesture may be caused by central nervous system defects and does not necessarily mean muscle weakness. To determine whether the mutant mice have muscular dystrophy, we examined tongue and leg muscles histologically. When analyzed in the newborns, POMGnT1 mutant mice did not show obvious differences from the wildtype animals. However, when analyzed at adulthood and compared with wildtype ( Fig. 4C) , the mutant tongue muscle showed rounding fibers and variation in size with groups of fat cell infiltration (Fig. 4D) . In leg muscle, a remarkable variability of fiber size with centralized myonuclei (see arrows in Fig. 4F ) was observed in the mutant. By contrast, centrally located nuclei were not found in the wildtype leg muscle (Fig. 4E) . Thus, there were dystrophic changes in the mutant skeletal muscle. Trichrome staining was carried out to determine whether there were signs of fibrosis. The results showed that fibrosis was not present in both tongue and leg muscle of mutant mice at the ages analyzed (about 3 months old and 6 months old), suggesting that the muscular dystrophic phenotype did not appear to be as severe as reported for fukutin-deficient chimeric mice (Takeda et al., 2003) and the Large myd mice (Holzfeind et al., 2002) . Unlike human MEB patients, we found no evidence of cardiac abnormalities in POMGnT1 mutant mice.
Developmental defects in brain
Abnormal neuronal migration in cerebrum and cerebellum has been found in MEB, WWS and FCMD in human and Large myd in mice (Holzfeind et al., 2002) . To determine if the same abnormalities are present in POMGnT1 mutant mice, we analyzed the brain histologically. Gross abnormalities were observed in the mutant brain. The mutant brain showed smaller cerebellum and thinner cerebral cortex (Fig. 5A ) when compared with the wildtype animals. H&E staining revealed that the cerebellar folia in mutant mice were smaller when compared to wildtype (Fig. 5B,C) . Folia 2 and 3 were not clearly discernable in the mutant. When viewed under higher magnifications, clumps of cells were observed above or between the cerebellar molecular layers in the mutant (Fig. 5E arrows) , while such clumps of cells were never observed in the wildtype cerebellum (Fig. 5D ). These clumps of cells are likely due to failed migration of granule cells from the external granule cell layer to the internal granule layer during cerebellar development. Immunoblot and laminin overlay analyses of dystroglycan in skeletal muscle. Western blot of WGA-enriched glycoproteins isolated from skeletal muscle of wildtype (C/C), heterozygous (C/K), and mutant (K/K) mice were carried out with antibodies to carbohydrate epitopes of a-dystroglycan (A,B) and anti-laminin antibody (D). Laminin binding activities were examined by a laminin overlay assay (C). b-dystroglycan was detected on Western blot of total muscle extract (E). Note that both IIH6C4 and VIA4-1 detected a-DG in C/C and C/K mice, but failed to detect a-DG in K/K mouse. Laminin binding activity was detected in both C/C and C/K mouse muscle, but was markedly reduced in K/K mouse. As controls, wildtype, heterozygous and mutant mice showed similar levels of laminin in WGA-enriched glycoproteins and similar levels of b-DG were observed in total muscle lysates as well.
Multiple abnormalities were observed in the forebrain. In normal cerebral cortex, layer I is a relatively cell sparse cortical layer (Fig. 6A) . The mutant cerebral cortex showed an abnormal distribution of neural cells with a seemingly disappearance of the molecular layer I in many areas of the mutant brains (Fig. 6B ) as compared to wildtype mice (Fig. 6A) . In mutants, cortical neurons appeared to overmigrate into layer I. The midline separation between two hemispheres is very clear in the wildtype mice (Fig. 6C) . In the mutant, the two cerebral hemispheres are fused in many regions (Fig. 6D ). Fig. 6G shows major hippocampal structures from the wildtype mice. In the mutant, the lower blade of the dentate gyrus (DG) appeared wavy and the CA3 cells failed to form a compact lamina and seemed to be separated into two layers (see arrow and compare Fig. 6H with Fig. 6G ). These forebrain abnormalities are observed in all of the mutant brains analyzed (nZ7). In addition, four out of seven mutant animals analyzed showed apparent hydrocephalus phenotype as revealed by the enlarged lateral ventricles (compare Fig. 6F with Fig. 6E ).
Abnormal development of eyes
The human phenotype for MEB and FCMD includes visual defects. An abnormal b-wave in electroretinography (ERG) is commonly noted in eye exams from muscular dystrophy patients (Pillers et al., 1993) . In POMGnT1 mutant mice, a number of severe anomalies were observed in both the retina and optic nerve in three out of five animals examined.
The optic nerves were much smaller in homozygous mutant mice as compared to those in wildtype mice (Fig. 7A) . Retinal abnormalities were also observed. The density of ganglion cells was greatly reduced in mutants both in the central (Fig. 7C ) and in the peripheral retina (Fig. 7E ) when compared to wildtype retinas (Fig. 7B,D, respectively) . In addition, the internal nuclear layer (INL) and outer nuclear layer (ONL) also appeared to be thinner in the mutant mice.
To further examine functional abnormalities in the POMGnT1 mutant retina, ERGs were conducted. Fig. 8 shows the ERG data compiled from nine wildtype, 14 heterozygous, and six homozygous animals. In wildtype mice, a series of ERG responses are plotted as a function of amplitude over time (Fig. 8A) . Each waveform is the average of 3-10 responses to a single flash of increasing intensities from top to bottom. In all waveforms, a positive going b-wave response generated by rod bipolar cells was predominant. As flash intensity increases (from bottom to top), an early negative going response appeared before the b-wave (top three traces). However, in POMGnT1 mutant mice, both a-and b-waves were reduced in amplitude and delayed in implicit time compared to wildtype mice (Fig. 8B) . Responses from wildtype, POMGnT1 mutant and POMGnT1 heterozygotes were quantified in terms of amplitude and implicit time for ERG a-and b-wave responses at each light intensity (Fig. 8C,D) . In all wildtype mice both the a and b-wave increased in amplitude (Fig. 8C,E) and decreased in implicit time (D and F) as flash intensity increases. However, responses from homozygous mutant mice were greatly reduced at each light intensity and were delayed in time. Additionally, the a-wave is only present in response to the highest intensity stimuli. These alterations in ERG of the POMGnT1 mutant mice indicate substantial retinal dysfunction originating in the photoreceptors and affecting most aspects of outer retinal function.
Discussion
The present study clearly demonstrates that a disruption of POMGnT1 by gene trapping in mice results in multiple defects in muscle, eye and brain, and are remarkably similar to the phenotypes observed in human MEB disease. Clinically, MEB resembles FCMD and WWS; all share the combination of congenital muscular dystrophy, brain malfunction and ocular abnormalities (Cormand et al., 1999) . Clinical characterization of MEB, FCMD and WWS in humans remains controversial (Dubowitz, 1997) . The recent discovery of the genes responsible for these diseases has made a definitive diagnosis possible. It is believed that genes encoding for POMGnT1, POMT1, fukutin and Large are involved in the same type of O-mannosylation of a-DG, since mutations in these genes generate a similar shift of molecular weight of a-DG Michele and Campbell, 2003) . However, the function of each of these enzymes appears to vary in the normal development of muscle, eye and brain. The present study provides a genetically identified mouse model to further dissect the role of POMGnT1 in MEB.
In mammals, the synthetic pathway of O-mannosylation is still not fully understood. It is postulated that the first step of O-mannosylation is catalyzed by POMT1 (or POMT2 depending on tissues), but it has been demonstrated that the second step is catalyzed by POMGnT1 (Endo, 1999) , which transfers GlcNAc through b1,2 linkage to O-linked mannosyl residue of glycoproteins. The additional sugar residues including galactose and sialic acid are sequentially added by specific enzymes. Several proteins were found to be O-mannosylated, including a-DG, proteoglycans, and tenascin-J1 (Lochter et al., 1991; Wing et al., 1992) and are likely substrates of these putative enzymes. a-DG is the best characterized potential target. Other cell/tissue-specific O-mannosylation targets may exist, but remain to be identified.
Immunoblot analyzes detected glycosylated forms of a-dystroglycan with monoclonal antibody IIH6C4 and VIA4-1 in the tissues of wildtype mouse skeletal muscle, but no signals were detected in POMGnT1 mutant mouse skeletal muscle, indicating the carbohydrate epitopes for IIH6C4 and VIA4-1 on a-dystroglycan were disrupted. Immunofluorescence staining results further confirmed that the signal of a-DG immunolabelling with antibody IIH6C4 was almost completely lost in POMGnT1 mutant mouse muscle compared to wildtype, which is also consistent with previous observations in human muscle . This is in agreement with previous studies in which no a-dystroglycan could be detected in muscle by IIH6C4 and VIA4-1 in MEB and FCMD patients (Grewal et al., 2001; Michele et al., 2002) and in Large myd mice (Holzfeind et al., 2002) with carbohydrate recognizing antibodies. The loss of epitope for antibody IIH6C4 and VIA4-1 in a-DG will abolish its binding activity for the ligands: laminin, neurexin and agrin, resulting in myodystrophy diseases (Grewal et al., 2001; Michele et al., 2002) . Indeed, ligand overlay assay revealed that the laminin binding activity of a-DG was markedly diminished in POMGnT1 mutant mice, suggesting that the interaction of a-DG with extracellular matrix laminin was significantly disrupted.
a-Dystroglycan bears multiple N-and O-linked oligosaccharides including an O-mannosyl chain that is very unique with mannose directly coupling to serine/threonine residue (Ibraghimov-Beskrovnaya et al., 1992) . Studies have shown that N-linked glycosylation is not required for ligand binding of a-dystroglycan; while the O-linked glycosylation is essential for ligand binding (Ervasti et al., 1993; Michele et al., 2002) . It is not clear which type of O-linked glycosylation on a-dystroglycan is required for ligand binding, and whether there are any interactions between different types of glycosylated chains. To better understand the function of a-dystroglycan, it may be necessary to further determine the fingerprint of a-DG carbohydrates. Interestingly, a recent study showed that in vitro overexpression of Large in cells derived from MEB, FCMD and WWS patients induced glycosylation of a-dystroglycan, and also could rescue ligand binding activities . It is possible that overexpressed Large may have rescued or substituted the functions of the defective genes. Alternatively, overexpressed Large may have consolidated the activities of other functionally similar genes that otherwise not able to compensate the genetic defect at normal levels of Large. It is also possible that overexpression of Large may allow a-DG to express different types glycosylation, which could partially resemble the configuration of natural (functional) a-dystroglycan, thus rescuing the binding activity of a-dystroglycan. Chemical deciphering of the glycosylation structures would provide valuable information. In this study, we also observed that a-dystroglycan in POMGnT1 mutant mice were hypoglycosylated and that laminin binding activity was abolished. Further studies will be required to determine whether hypoglycosylation of a-dystroglycan is a direct cause of these phenotypes.
It is interesting to note that there are phenotypic differences between POMGnT1 mutant mice and Large myd mice. Histological analysis revealed broad structural disruption in the brain of POMGnT1 mutant mice, including an obliterated molecular layer and abnormal neuronal migration in cerebral cortex, similar to that observed in Large myd mice (Holzfeind et al., 2002) . One of the pathological differences between POMGnT1 mutant and Large myd mice was in the hippocampus. In all POMGnT1 mutant mice, the CA3 cells failed to form a compact lamina, and the granular cells in the dentate gyrus were disorganized. However, in Large myd mice, these abnormalities were not consistent, being found in only a few mutant animals (Holzfeind et al., 2002) . With respect to the hippocampus phenotype, brain specific knockout of dystroglycan resulted in more consistent abnormalities similar to POMGnT1 mutant mice reported here .
The retinal abnormalities in Large myd mutant may exhibit variations depending on genetic background. An earlier study found no obvious abnormalities in the eye or retina Note that the mutant retina has fewer ganglion cells especially in the peripheral retina. In addition, the retinal layers are thinner in the mutant. Abbreviations: INL, inner nuclear layer; ONL, outer nuclear layer; RGL, retinal ganglion cell layer. Scale bar in E, 100 mm for B-E. (Holzfeind et al., 2002) although ERG showed that the b-wave amplitude and implicit time was changed. However, a more recent study of Large myd mutant in C57BL/6 background revealed structural changes in retinal histology in addition to abnormal ERG (Lee et al., 2005) . The mutant retina was thinner with reduced retinal ganglion cell density. Similarly, severe retinal abnormalities were observed in POMGnT1 mutant mice including thinner retina and decreased density of ganglion cells. The ERG study clearly showed that both a-and b-waves were affected, indicating the substantial dysfunction in the photoreceptors and transmission of photoreceptor signal to bipolar cells.
Although dystrophic abnormalities were observed in the tongue and leg muscle of POMGnT1 mutant mice including the fibers size, internalization of myonuclei and fatty infiltration, no severe fiber necrosis was detected. However, in Large myd mice more severe dystrophic changes were developed including fibrosis, endomysial connective and fatty tissue (Holzfeind et al., 2002) . The phenotypic differences in hippocampus and skeletal muscle may partially reflect distinct cell/tissue-specific functions of POMGnT1 and Large. The fact that overexpression of Large in cells isolated from WWS and MEB patients results in hyperglycosylation of a-dystroglycan while overexpression of POMGnT1 fails to do so supports this notion.
In summary, although similarities were found in the Large myd and POMGnT1 mutant mouse, phenotypic differences were also observed. Particularly, POMGnT1 mutant model exhibited more severe phenotypes in the brain and eye but muscular dystrophic changes seemed less severe when compared to Large myd mice. There have been several mouse models reported with mutations in these presumed protein glycosyltransferases. It is interesting to note that while Large myd and POMGnT1 mutant mouse survive, both fukutin and POMT1 mutants are embryonic lethal. One may speculate that both POMT1 and fukutin may be involved in earlier steps of glycosylation of a-dystroglycan or there may be functional redundancies for POMGnT1 and Large proteins. Indeed, a novel functionally related Large2 gene has been recently reported. It is not known whether there are similar POMGnT1 related genes. POMGnT1 mutant mice offer an additional model that can provide tissues for biochemical and molecular pathological studies of the disease process.
Experimental procedures
Generation of POMGnT1 gene trapped mice
At Lexicon Genetics Incorporated (The Woodlands, TX), a systematic effort of targeting the entire mouse genome by gene trapping has been carried out. By random insertion of trapping vectors into the genome of mouse embryo stem cells, various genes have been trapped, identified by 3 0 RACE and catalogued in the OmniBank database (Zambrowicz et al., 1998) . We searched the OmniBank database with human POMGnT1 cDNA sequence and identified an ES cell line named OST179231, in which POMGnT1 gene was trapped at exon 2 (Fig. 1) . The POMGnT1 promoter directs the transcription of a fusion transcript derived from 5 0 UTR and 41 nucleotides reading frame of POMGnT1 and b-Geo (a fusion between the b-galactosidase and neomycin resistance genes). The trapping vector contains its own promoter located in Pgk (mouse phosphoglycerate kinase gene) that directs the transcription of the cassette Btk gene and splices to the downstream exons of POMGnT1. Since Btk contains termination codons in its reading frame, which will prevent the translation of 3 0 -end fusion transcript.
To create POMGnT1 mutant mice, the OST179231 ES cells were injected into the C57BL/6 blastocysts to generate chimeras. The ES cells used were derived from the 129/SvEvBrd strain. A total of four chimeric mice were obtained and crossbred with C57BL/6J albino mice to generate heterozygote, and then heterozygote mice were mated to produce homozygote mice.
All mice analyzed were of mixed genetic background (129/SvEvBrd and C57BL/6J). Handling of experimental animals was conducted in accordance with the Animal Care guidelines of SUNY Upstate Medical University.
Genotyping of mice
To identify wildtype, heterozygous and homozygous animals, PCR amplification was performed. Genomic DNA was isolated from the tails as described previously (Liu et al., 2003) . PCR amplification was carried out by the following cycling conditions: 95 8C for 15 s, 62 8C for 30 s and 72 8C for 30 s (35 cycles) with a final extension at 72 8C for 5 min. The PCR products were loaded on 2% ethidium bromide-agarose gel and photographed under UV light. Wildtype primers were forward (F): 5 0 GCCATTAAGCTT TGGGACAA3 0 , and reverse (R): 5 0 AGCTCCGTTTCTTCCTAGCC3 0 , which flank the retroviral insertion site (Fig. 1A) . Wildtype allele gives a product of about 170 bp. For the mutant alleles, a forward primer derived from LTR of the retroviral vector (RV) 5 0 AAATGGCTGTACTTAAGC TAGCTTGC3 0 was used in combination with wildtype reverse primer (R, Fig. 1B ). The mutant allele gives a product about 140 bp. If a single 170 bp PCR product is amplified from primers F and R, it indicates the sample is derived from wildtype mouse. If both 170 and 140 bp products are detected, indicating that the sample is from heterozygous mouse. The homozygous mouse only produces a 140 bp DNA fragment on agarose gel. To confirm if POMGnT1 transcript was expressed in gene trapping mice, RT-PCR was used to amplify a 217 bp cDNA, a region encoding the partial POMGnT1 catalytic domain (Taniguchi et al., 2003) . Total RNAs were extracted from 2-month-old mutant skeletal muscle, in which POMGnT1 is highly expressed (Yoshida et al., 2001 ). The RT reactions were performed using 5 mg of total RNAs with SuperScript II and random hexamer primers (Invitrogen). PCR amplification was performed using the cycling conditions: 95 8C for 30 s, 60 8C for 45 s and 72 8C for 45 s (30 cycles) with a final extension at 72 8C for 5 min, with a pair of oligonucleotide primers (forward: 5 0 ATCCTACCCTTTGGCATCG3 0 and reverse: 5 0 TGTCTGGCAG GAAGGAGTCT3 0 ) complementary to POMGnT1 cDNA encoding catalytic domain. As a control, a pair of b-actin primers was also used to show the same amount of total RNA used in RT-PCR reactions (Liu et al., 2003) .
Affinity chromatography
Affinity chromatography was performed as previously described with minor modifications (Michelele et al., 2002) . Briefly, the skeletal muscle and brain tissues (0.3 g) from wildtype and mutant mice were homogenized by polytron in 3 ml TBS (50 mM Tris-HCl, 150 mM NaCl, pH 7.4)C proteinase inhibitors cocktail. Then Triton X-100 was added to above homogenate at the final concentration 1%, and the homogenized tissues were incubated with gentle mixing at 4 8C for 1 h and centrifuged at 14,000!g for 37 min. The supernatant was collected and incubated with 300 ml washed WGA agarose beads (Vector Laboratories, Inc) at 4 8C overnight. The beads were then washed 3! with TBS containing 0.1% Triton X-100 and proteinase inhibitor cocktail, and resuspended in 1 ml TBSC0.1% Triton X-100 or 1 X SDS loading buffer and heated in boiling water for 5 min and stored at K70 8C until analysis.
Antibodies, immunoblotting and ligand overlay analyses
Monoclonal antibody IIH6C4 and VIA4-1, which recognizes carbohydrate epitopes of a-DG, was purchased from Upstate (Lake Placid, NY), monoclonal antibody against laminin was from Santa Cruz Biotechnology, INC. (Santa Cruz, CA), and the anti-a-DG and anti-b-DG antibody were from BD Biosciences. The secondary antibodies anti-mouse IgG and IgM conjugated with horseradish peroxidase were purchased from Abcam, Inc.
The cytosol and cell membrane proteins were prepared by using BioVison Kit (Mountain View, CA). Briefly, tissues were homogenized on ice in homogenization buffer supplemented with proteinase inhibitor cocktail and centrifuged at 30,000!g for 1 h at 4 8C. The supernatants containing cytosolic proteins were collected and stored at K70 8C until analysis. The crude pellets containing membranes, nuclei, and mitochondria were sonicated (5 s/cycle; 4 cycles) in sonication buffer (20 mM Tris, 50 mM EDTA, 0.1 mM DEDTC, pH 8.0) containing 32 mM octyl glucoside. The sonicates were centrifuged at 13,000!g for 25 min at 4 8C. The supernatants (containing total cell membrane protein) were stored at K70 8C until immunoblot analysis. The protein concentration was determined by the method of Bradford.
For a-DG, 30 ml WGA eluted supernatant was loaded onto 4-20% SDS-PAGE, for the laminin overlay and the b-DG, fifty micrograms of cell membrane extracts were separated by 4-20% SDS-PAGE and electrophoretically transferred onto nitrocellulose filters. Filters were blocked by 5% skim milk in TBS, incubated with primary antibody and then secondary antibody conjugated with HRP was applied. The results were visualized by ECL detection kit. For laminin overlay assay , after filter was blocked, filter was incubated with laminin (1 mg/ml) overnight at 4 8C, then was washed and probed with anti-laminin antibody followed by HRP-anti-rabbit IgG, visualized by ECL detection kit.
Histological and immunofluorescence analyses
Tissues were fixed in 10% formalin and embedded in paraffin, and cut into 10-mm thick sections. The sections were deparaffinized through graded alcohol series. Some tissues were quick frozen and processed for cryostat sections. Immunohistochemical staining was performed as described previously (Hu, 1999; 2000; Liu et al., 2003) .
Electroretinography
To evaluate retinal function, full field electroretinograms (ERGs) were recorded at 2-4 months of age in dark-adapted anesthetized (ketamine, 80 mg/kg and xylazine, 16 mg/kg) mice. Following pupil dilation with 1% mydriacyl and 2.5% phenylephrine, animals rested on a heating pad while ERGs were recorded using a wire-loop recording electrode, which made contact with the corneal surface of the eye through a thin layer of 2% methylcellulose. Two platinum needle electrodes placed in the cheek and tail served as reference and ground, respectively. Signals were band-passed amplified (1-1000 Hz), digitized at 2500 Hz, and averaged using an Utas 4000 LKC signal averaging system (Gaithersburg, MD). Light flashes ranging from K3.0 to 1.0 log cd s/m 2 were presented in a ganzfeld. ERG a-and b-wave amplitudes were measured from baseline to the trough of the negative-going a-wave and from the trough of the a-wave to the peak of the subsequent positive-going b-wave. Implicit times were noted as time of trough for the a-wave and time of peak for the b-wave following stimulus onset.
